PPRC1 and central nervous system cancer: Recent studies found COL5A1 was positively correlated with the increasing malignancy of glioblastoma through the PPRC1-ESM1 axis activation and extracellular matrix remodeling, and it may be a potential therapeutic target for glioma [53-56].